Suppr超能文献

免疫抑制后神经皮肤黑素沉着症(NCM)的恶性转化

Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression.

作者信息

Schaff Lauren R, Marghoob Ashfaq, Rosenblum Marc K, Meyer Rina, Khakoo Yasmin

机构信息

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York City, New York.

Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York City, New York.

出版信息

Pediatr Dermatol. 2019 Jul;36(4):497-500. doi: 10.1111/pde.13804. Epub 2019 Mar 13.

Abstract

Neurocutaneous melanosis (NCM) is the condition of abnormal melanocyte deposition in the leptomeninges and brain parenchyma. Associated with congenital melanocytic nevi, NCM can result in neurologic deficits, hydrocephalus, and rarely, malignant transformation of cells. We present the case of a 16-year-old boy with NCM who developed malignant leptomeningeal melanoma following immunosuppression with a TNFα inhibitor. To our knowledge, this is the first reported case of a patient with known NCM undergoing malignant transformation after anti-TNF therapy for inflammatory bowel disease.

摘要

神经皮肤黑素沉着症(NCM)是一种软脑膜和脑实质中黑素细胞异常沉积的病症。NCM与先天性黑素细胞痣相关,可导致神经功能缺损、脑积水,细胞恶变则较为罕见。我们报告了一例16岁患有NCM的男孩病例,该男孩在使用肿瘤坏死因子α抑制剂进行免疫抑制治疗后发生了恶性软脑膜黑色素瘤。据我们所知,这是首例已知患有NCM的患者在接受抗TNF治疗炎性肠病后发生恶变的病例报告。

相似文献

4
Neurocutaneous melanosis.神经皮肤黑素沉着症
J Craniofac Surg. 2005 Sep;16(5):874-6. doi: 10.1097/01.scs.0000181050.06696.4d.
6
Neurocutaneous melanosis.神经皮肤黑素沉着症
Childs Nerv Syst. 2004 Jan;20(1):23-8. doi: 10.1007/s00381-003-0835-9. Epub 2003 Oct 24.

本文引用的文献

8
Primary cutaneous melanoma: a complication of infliximab treatment?原发性皮肤黑色素瘤:英夫利昔单抗治疗的一种并发症?
Clin Exp Dermatol. 2009 Jun;34(4):524-6. doi: 10.1111/j.1365-2230.2008.02970.x. Epub 2009 Jan 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验